From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winifrith bonus Bearcast: The Botswana Covid variant and a tumbling stockmarket

By Tom Winnifrith | Friday 26 November 2021


 


How many folks have tested for this variant in the UK or died from it in the country where it is most prevalant – not Botswana? Or even been hospitalised by it in the epicentre?  The answer is the same number of times that I have shagged Cheryl Cole this week. But the market is tumbling. I discuss the real data behind this variant, the wild scaremongering and whether this is a buying opportunity in the world of shares? I referred to a bird from Edinburgh University who is the worst of the experts on forecasting HERE and to data from three continguous US states HERE, from Wales and England HERE and from central European countries centred on Hungary HERE.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 07:13:24